• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Open . Seroprevalence and demographic characteristics of SARS-CoV-2-infected residents of Kibera informal settlement during the COVID-19 pandemi

tetano

Editor, Senior Moderator
BMJ Open


. 2025 Apr 2;15(4):e094546.
doi: 10.1136/bmjopen-2024-094546. Seroprevalence and demographic characteristics of SARS-CoV-2-infected residents of Kibera informal settlement during the COVID-19 pandemic in Nairobi, Kenya: a cross-sectional study

Jane Y Carter[SUP] 1 [/SUP], Samoel Khamadi[SUP] 2 [/SUP], Joseph Mwangi[SUP] 2 [/SUP], Samuel Muhula[SUP] 3 [/SUP], Stephen M Munene[SUP] 4 [/SUP], Lucy Kanyara[SUP] 2 [/SUP], Joyceline Kinyua[SUP] 2 [/SUP], Nancy Lagat[SUP] 2 [/SUP], Judy Chege[SUP] 2 [/SUP], Robert Oira[SUP] 2 [/SUP], Alex Maiyo[SUP] 2 [/SUP], Roy Stewart[SUP] 5 [/SUP], Maarten Postma[SUP] 6 7 8 9 [/SUP], Jelle Stekelenburg[SUP] 6 10 [/SUP], Joachim Osur[SUP] 11 [/SUP], Marinus van Hulst[SUP] 6 12 [/SUP]



Affiliations
Abstract

Objectives: To assess the prevalence of SARS-CoV-2 antibodies in the residents of Kibera informal settlement in Nairobi, Kenya, before vaccination became widespread, and explore demographic and health-related risk factors for infection.
Design: A cross-sectional study.
Setting: Kibera informal settlement, Nairobi, Kenya.
Participants: Residents of Kibera informal settlement between October 2019 and August 2021, age 1 year and above who reported no current symptoms of COVID-19.
Main outcome measures: Associations were determined between SARS-CoV-2 positive tests measured with one rapid test and two ELISAs and demographic and health-related factors, using Pearson's χ[SUP]2[/SUP] test. Crude OR and adjusted OR were calculated to quantify the strength of associations between variables and seropositive status.
Results: A total of 438 participants were recruited. Most (79.2%) were age 18-50 years; females (64.2%) exceeded males. More than one-third (39.1%) were unemployed; only 7.4% were in formal, full-time employment. Less than one-quarter (22.1%) self-reported any underlying health conditions. Nearly two-thirds (64.2%) reported symptoms compatible with COVID-19 in the previous 16 months; only one (0.23%) had been hospitalised with a reported negative COVID-19 test. 370 (84.5%) participants tested positive in any of the three tests. There was no significant difference in SARS-CoV-2 seropositivity across age, sex, presence of underlying health conditions, on medication or those ever tested for SARS-CoV-2. Multiple logistic regression analysis showed that COVID-19 symptoms in the previous 16 months were the only significant independent predictor of seropositivity (p=0.0085).
Conclusion: High SARS-CoV-2 exposure with limited morbidity was found in the residents of Kibera informal settlement. The study confirms other reports of high SARS-CoV-2 exposure with limited morbidity in slum communities. Reasons cited include the high infectious disease burden on the African continent, demographic age structure and underreporting due to limited testing and lack of access to healthcare services; genetic factors may also play a role. These factors require further investigation.

Keywords: COVID-19; Community-Based Participatory Research; EPIDEMIOLOGY; PUBLIC HEALTH.

 
Back
Top Bottom